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INFECTIOUS MONONUCLEOSIS 
AND E.B. VIRUS INFECTION
ELIZABETH EDMOND
The Disease
Infectious mononucleosis has long been an 
enigma to epidemiologists. The absence of a re­
cognised casual agent or a specific diagnostic test 
has thrown confusion on such basic issues a s the 
definition of the disease. Until very recently the 
diagnosis has had to be based on a triad consist­
ing of characteristic s igns and symptoms, an 
absolute increase in atypical mononuclear cells, and 
a positive heterophile aggultination (Paul Bunnell 
test) test. Unfortunately each of these criteria is 
subject to variation in interpretation while the rigid 
application of the three allows no margin for the 
d iagnosis of subclinical or atypical disease. Within 
these limits of diagnosis, work on the epidemiology 
of the disease has produced very few concrete re­
sults. While there is no doubt that infectious mono­
nucleosis has a peak incidence in young adults 
and is relatively uncommon in childhood and older 
age groups, the evidence concerning infectivity, 
incubation period and methods of transmission has 
been circumstantial and often based on a small 
number of observations. Conclusions drawn from 
such work suggests that although the disease 
occasionally develops in contacts it is not highly 
contagious, and there remains doubt a s to whether 
epidemics of the classical disease have ever 
occurred. Estimations of the incubation period 
range between very wide limits, and although there 
is some evidence that the causal agent is trans­
mitted in saliva (hence the term "k issing  d isease”) 
the method of natural transmission is still unproven.
Many of these problems of the behaviour of in­
fectious mononucleosis could be solved if a specific 
causal agent could be recognised and during the 
last six years the accumulation of evidence implicat­
ing the EB  virus has caused considerable interest 
amongst epidemiologists.
The Virus
The Epstein-Barr virus was described in 1964 
when it was found to be present in cells cultured 
from a Burkitt Lymphoma. Its role in the production 
of the tumour remains an exciting controversial pro­
blem which cannot be dealt with here. All attempts 
to propagate the virus in other types of cell lines 
have so  far been unsuccessful, and only human 
lymphoid haemopoietic cells will allow the virus 
to replicate. Antibody to the viral capsid antigen 
carried in the cells can be detected by an indirect 
immunofluorescence test described by Henle in 
1966. Serological surveys using this technique
showed that although antibody to the virus is present 
in all sera from patients with Burkitt Lymphoma, the 
antibody is also widely distributed in populations 
throughout the world regardless of the incidence of 
the tumour. Thus the incidence of EB  viral capsid 
antibody in some students groups in Edinburgh is 
shown in Table I.
Table 1 Inc idence o f EBV antibody in  hea lthy students
Population Age Sex
Year sera 
withdrawn
No. sera 
tested
*  EBV 
antibody +ve.
1st y r .  P.E.
College 18 F 1968 55 85
1969 40 90
1970 115 85
4th y r . M
Medical Students 21 4 F 1965 130 71
1970 122 64
U n iv e rs ity
“Freshers'* ,18 1970 36 72
Table II represents the age incidence of EB  virus 
antibodies in hospital patients in Edinburgh. This is 
very similar to the age incidence reported from 
U.S.A., Scandinavia and England, and demonstrates 
that 3 2 %  of children already have antibody by the 
age of four years.
Age Incidence of Antibodies to E B Virus in Hospital Patients Edinburgh 
1968-1970
100
E B V *
40 -
2 0 -
104
54
0 -3
months
4-12
months
13-24
months
2 -4
years
51 4
years
15-24
years
25+
years
Table II
10
In order to explain the universal occurrence and 
common pattern of age incidence of EB virus anti­
body, attempts were made to link production of this 
antibody with common infectious diseases. A chance 
occurrence in the Henle’s laboratory in Philadelphia 
suggested that the antibody might be produced dur­
ing the course of infectious mononucleosis. In con­
junction with workers in Yale who had stored sera 
from patients with infectious mononucleosis for 
many years, they were able to demonstrate that 
sera taken from students before the onset of in­
fectious mononucleosis were devoid of antibody 
while sera from the same students taken during the 
acute phase of the disease all had high titres of 
antibody to the virus. Furthermore, once developed, 
antibody to the virus persisted for many years, 
probably for life.
These findings have been confirmed and extended. 
Recent reports of the finding of macromolecular 
EBV antibody in the early stages of infectious mono­
nucleosis and one report of the isolation of the virus 
from the throat of an acute case, make the case 
against EB virus almost watertight. Despite the 
doubtful ethics of the problem infectious mono­
nucleosis has been produced on one occasion 
following injection of virus in a human volunteer.
There remain however many questions to be 
answered. In particular how is the virus spread?, 
do healthy carriers exist?, how much, if any, of the 
heterophile antibody negative disease is caused by 
EBV?, and what clinical syndromes other than 
classical infectious mononucleosis can be caused 
by infection with EBV? The fluorescent antibody test 
is positive in 80% of normal adults and therefore 
does not give a specific indication of disease —  is 
the demonstration of EBV IgM antibody helpful in 
the diagnosis of atypical disease or can other 
specific tests of current infections be developed?
Edinburgh Student Virus Survey
It was with these unanswered questions in mind 
that the Edinburgh Student Virus Survey was 
initiated in October 1971. The survey was brought 
to the notice of individual students at the time of 
the matriculation chest x-ray and a sample of venous 
blood taken from volunteers, who also provided 
details of previous medical and social history. Sera 
were tested for antibody to EBV and as a service to 
female students also to rubella virus. Those students 
who were without antibody to EBV were requested 
to attend the Student Health Service again in May, 
1972. At the second interview details of any illness 
occurring in the previous six months were noted 
and another sample of blood withdrawn for testing. 
In addition, with the co-operation of the physicians 
of the Student Health Service serial serum samples 
have been obtained from students who are unfort­
unate enough to contract illness which might be 
infectious mononucleosis.
Female students at Dunfermline College of 
Physical Education have been taking part in a 
similar survey started in October, 1970.
Results
Preliminary results of the first year of the survey 
are shown in Tables III - V.
A total of 613 sera were obtained from university 
student volunteers and 65% were found to possess 
antibody to EBV. There appears to be a higher sero- 
positivity rate in the female students.
Table III.
SERA COLLECTED OCTOBER, 1971
M F Total
Nos. of sera screened ........ 322 281 613
n o . EBV antibody positive .. 199 200 399
% EBV antibody positive ... 59.9 71. 65.
Table IV.
RESULTS FIRST FOLLOW UP (May 1972)
No. of 2nd sera available ................................ 164
No. EBV antibody positive ...........................  18
% Conversions ........................................  11
Table V Incidence of 11 loess in Initial Seronegative Group
Group Total No.
Proven 
or suspected I.M.
Other
Symptoms
No
symptoms
Sero-
conversions
18 5 6 7
Persistent
seronegatives
146 0 54 92
After approximate seven months of academic life 
18 of those students initially seronegative were found 
to have produced EBV antibody, giving a conversion 
rate of 11%.
Table V shows that of the 18 students known to 
have acquired EBV antibody in the seven months 
following their entry to university, 5 (28%) had been 
investigated as possible cases of infectious mono­
nucleosis, while 7 (39%) had no symptoms of any 
kind. Other symptoms, mainly sore throats, were 
reported by 6. In contrast none of the 144 volunteers 
who remained seronegative were suspected of hav­
ing infectious mononucleosis.
A small number of sera from patients in the acute 
phase of infectious mononucleosis have been in­
vestigated in this first year. It has been found that 
by the time the patient presents with symptoms, anti­
body to EBV measured by the fluorescence method 
is already present at high titre, and little change can 
be detected during the course of the illness. Anti­
body measured by the complement fixation reaction 
however appears to rise much more slowly and may 
not become positive until several months after the 
illness. If this is true then a combination of fluores­
cence antibody and complement fixing antibody may 
give a valuable indication of the timing of infection.
It is hoped that this, and many other aspects of 
the disease will be clarified in the next two years 
of the survey. The numbers involved at this stage are 
still small but in October 1972 a further 1,000 stud­
ents have volunteered to take part. We would like to 
take this opportunity of thanking all our student 
volunteers and look forward to providing more 
details of the results at some future date.
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